Google Übersetzer
Fibrobiologics, Inc. Common Stock
About
Fibrobiologics, Inc. Common Stock (NASDAQ:FBLG) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
FibroBiologics Compliant with All Nasdaq Listing Requirements
Apr 10 2026
FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
Apr 2 2026
FibroBiologics Announces Closing of $3 Million Public Offering
Mar 31 2026
FibroBiologics Announces Pricing of $3 Million Public Offering
Mar 31 2026
FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial
Financials
Revenue
$0
Market Cap
$6.22 M
EPS
-8.40